Our Stock of the Week is OptimizeRx (OPRX). OPRX is a healthcare technology company that provides digital health services that connect pharmaceutical companies, healthcare providers, and patients.
Its primary focus is to enhance medication adherence, improve patient outcomes, and streamline communication using a data-driven, AI-powered platform that is integrated into healthcare workflows. OptimizeRx delivers targeted messages, educational content, and financial support tools such as co-pay and discount cards to health care providers and patients through its digital platform. A doctor using the health records of a patient might receive real-time alerts about a medication’s benefits or patient assistance programs during a patient visit.
OPRX’s Health care provider marketing program delivers clinical and financial information to providers at the point of care, increasing prescription relevance and its Direct-to-Consumer (DTC) Marketing: Uses Micro-Neighborhood® Targeting to reach patients with tailored messages before key care moments. This achieves an average 28:1 prescription campaign ROI. The OPRX platform connects over 2 million U.S. health care providers and millions of patients through a proprietary network.
The company is enjoying very fast growth with revenue jumping 55% in the second quarter to $29.2 million and eps of $0.24 versus estimates of just $0.02. The company expects 2025 eps of $0.65, which is 100% growth. It trades with a trailing P/E of 23.
Roth Capital raised its price target for OPRX to $27 from $22 following the very strong second quarter report, which was sharply above forecasts. The analyst states that OptimizeRx is well-positioned for accelerated growth in 2025 and beyond. Current revenue growth guidance is still muted at just 13%-17%,
There are four analysts with buy ratings on the stock with an average target price of $21.67 versus the current price of $17.15.
The stock trades quite thinly and can be volatile with a large spread. My game plan is to watch for opportunities to accumulate as the chart develops and to trade it aggressively.
This post is for educational purposes only! This is not advice or a recommendation. We do not give investment advice. Do not act on this post. Do not buy, sell, or trade the stocks mentioned herein. We WILL actively trade this stock differently than discussed herein. We will sell into strength and buy or sell anytime for any reason. We will actively trade into any unusual activity. At the time of this post, principals, employees, and affiliates of Shark Investing, Inc. and/or principals, clients, employees, and affiliates of Hammerhead Financial Strategies, LLC, directly or indirectly, controlled investment and/or trading accounts containing positions in OPRX. To accommodate the objectives of these investing and/or trading accounts, the trading in these shares will be contrary to and/or inconsistent with the information contained in this posting.
